Ensysce Biosciences (ENSCW) Other Operating Expenses (2018 - 2020)
Ensysce Biosciences (ENSCW) reported Other Operating Expenses of $915183.0 for Q1 2020, up 383.78% year-over-year from $189174.0 in Q2 2019, and down 52.56% quarter-over-quarter from $1.9 million in Q4 2019.
Ensysce Biosciences (ENSCW) Other Operating Expenses (2018 - 2020) Analysis & Trends
Ensysce Biosciences (ENSCW) has 3 years of Other Operating Expenses data on file, last reported at $915183.0 in Q1 2020.
- Other Operating Expenses for Q1 2020 came in at $915183.0, up 383.78% year-over-year; the trailing twelve-month figure through Dec 2020 was $915183.0 (down 72.51% YoY), and the FY2019 annual result was $3.3 million, up 113.48% from the prior year.
- Other Operating Expenses fell to $915183.0 in Q1 2020 per ENSCW's latest filing, from $1.9 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $1.9 million in Q4 2019 and troughed at $170134.0 in Q1 2018.
- A 3-year average of $644789.1 and a median of $584418.0 in 2019 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 741.02% in 2019 and fell as far as 31.1% in 2019.
- A 3-year view of Other Operating Expenses shows it stood at $229381.0 in 2018, then surged by 741.02% to $1.9 million in 2019, then slumped by 52.56% to $915183.0 in 2020.
- Business Quant data shows ENSCW's Other Operating Expenses at $915183.0 in Q1 2020, $1.9 million in Q4 2019, and $584418.0 in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ensysce Biosciences | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 915,183.00 |
| Dec 31, 2019 | 1.93 Mn |
| Sep 30, 2019 | 584,418.00 |
| Jun 30, 2019 | 625,938.00 |
| Mar 31, 2019 | 189,174.00 |
| Dec 31, 2018 | 229,381.00 |
| Sep 30, 2018 | 848,192.00 |
| Jun 30, 2018 | 311,538.00 |
| Mar 31, 2018 | 170,134.00 |